COP:TRIN

We are currently running an ongoing trial with the hypothesis that in patients who are urgently admitted and who have a positive test for 2019-nCoV and symptoms similar to COVID-19 disease, treatment with corona virus inhibitor hydroxychloroquine as well as virus-immunomodulatory and antibacterial drug azithromycin can lead to shorter hospitalisation and fewer admissions in the intensive care unit

Read more about the trial and get recent updates here.